Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Palaskas

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Cardiovascular Medicine|July 16, 2021
Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL AmyloidosisAli M Agha, Nicolas Palaskas, Amit R Patel, et al.
Frontiers in Cardiovascular Medicine|February 10, 2023
Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosisEfstratios Koutroumpakis, Adam Niku, Christopher K Black, et al.
The American Journal of Cardiology|February 16, 2019
Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint InhibitorsNicolas Palaskas, Jacob Morgan, Tina Daigle, et al.
The American Journal of Cardiology|September 6, 2018
Safety of Diagnostic and Therapeutic Cardiac Catheterization in Cancer Patients With Acute Coronary Syndrome and Chronic ThrombocytopeniaCezar Iliescu, Dinu V Balanescu, Teodora Donisan, et al.
International Journal of Cardiology|August 29, 2020
Transcatheter and surgical aortic valve replacement impact on outcomes and cancer treatment scheduleClarence Gill, Michelle Lee, Dinu Valentin Balanescu, et al.
Frontiers in Cardiovascular Medicine|March 3, 2020
Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and ThromboelastographyAli M Agha, Clarence Gill, Dinu Valentin Balanescu, et al.
Haematologica|November 11, 2021
Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomaRaphael E Steiner, Jose Banchs, Efstratios Koutroumpakis, et al.
International Journal of Cardiology|December 28, 2020
Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysisRiyad Y Kherallah, Darren Harrison, Ourania Preventza, et al.
JAMA Cardiology|July 7, 2021
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative ReviewLorenz H Lehmann, Jennifer Cautela, Nicolas Palaskas, et al.
Journal of Cardiac Failure|October 16, 2024
Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician: a Supplement to the Scientific Statement from the Heart Failure Society of AmericaMichelle Weisfelner Bloom, Jacqueline B Vo, Jo E Rodgers, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Cardiovascular Medicine|July 16, 2021
Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL AmyloidosisAli M Agha, Nicolas Palaskas, Amit R Patel, et al.
Frontiers in Cardiovascular Medicine|February 10, 2023
Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosisEfstratios Koutroumpakis, Adam Niku, Christopher K Black, et al.
The American Journal of Cardiology|February 16, 2019
Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint InhibitorsNicolas Palaskas, Jacob Morgan, Tina Daigle, et al.
The American Journal of Cardiology|September 6, 2018
Safety of Diagnostic and Therapeutic Cardiac Catheterization in Cancer Patients With Acute Coronary Syndrome and Chronic ThrombocytopeniaCezar Iliescu, Dinu V Balanescu, Teodora Donisan, et al.
International Journal of Cardiology|August 29, 2020
Transcatheter and surgical aortic valve replacement impact on outcomes and cancer treatment scheduleClarence Gill, Michelle Lee, Dinu Valentin Balanescu, et al.
Frontiers in Cardiovascular Medicine|March 3, 2020
Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and ThromboelastographyAli M Agha, Clarence Gill, Dinu Valentin Balanescu, et al.
Haematologica|November 11, 2021
Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomaRaphael E Steiner, Jose Banchs, Efstratios Koutroumpakis, et al.
International Journal of Cardiology|December 28, 2020
Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysisRiyad Y Kherallah, Darren Harrison, Ourania Preventza, et al.
JAMA Cardiology|July 7, 2021
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative ReviewLorenz H Lehmann, Jennifer Cautela, Nicolas Palaskas, et al.
Journal of Cardiac Failure|October 16, 2024
Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician: a Supplement to the Scientific Statement from the Heart Failure Society of AmericaMichelle Weisfelner Bloom, Jacqueline B Vo, Jo E Rodgers, et al.
Pageof 7